跳至主要内容
临床试验/NCT06013774
NCT06013774已完成不适用

Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment Procedure

UMC Utrecht1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2021年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
UMC Utrecht
入组人数
12
试验地点
1
主要终点
Device Feasibility

研究概览

简要总结

To establish the safety and feasibility of interventional x-ray and scintigraphy imaging during the pre-treatment procedure of hepatic radioembolization

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must have given written informed consent and comply with the requirements of the study protocol.
  • Must be aged 18 years or over.
  • Must be selected to undergo a 99mTc-MAA procedure as part of their radioembolisation treatment.
  • Sufficiently fit to undergo an additional examination time of 30-90 minutes.
  • Have a CT acquired less than 6 weeks before the pre-treatment radioembolisation procedure.

排除标准

  • Patients expected to require more than two injection positions for radioembolisation treatment.
  • Pregnancy or nursing.
  • Patients suffering from psychic disorders that make a comprehensive judgement impossible, such as psychosis, hallucinations and/or depression.
  • Patients who are declared incompetent.
  • Previous enrollment in the present study
  • Claustrophobia
  • The last dose of prior chemotherapy has been received less than weeks prior to the planned 99mTc-MAA pre-treatment procedure.
  • Radiation therapy within the last 4 weeks before the planned 99mTc-MAA pre-treatment procedure
  • Major surgery within the last 4 weeks prior to the planned 99mTc-MAA pre-treatment procedure
  • Any unresolved toxicity greater than Common Terminology Criteria for Adverse Events (CTCAE version 5) grade 2 from previous anti-cancer treatment
  • Body weight over 250 kg (because of maximum table load)
  • Patient length over 1.90 m (to fit IXSI geometry)
  • Patient bust line over 135 cm (to fit IXSI geometry)

结局指标

主要结局

Device Feasibility

时间窗: Immediately after surgery

The feasibility of IXSI will be assessed by questionnaires filled in by interventional radiology personnel

次要结局

  • Radioactivity distribution over time(Immediately after surgery)
  • Radioactivity distribution in 3D(Immediately after surgery)

研究者

发起方
UMC Utrecht
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hugo de Jong

Principal Investigator

UMC Utrecht

研究点 (1)

Loading locations...

相似试验